[Correlation between clinical manifestation, prognosis and antibody in anti-muscle-specific tyrosine kinase antibody positive myasthenia gravis].

Tan, Y; Zhu, L; Huang, Y Y; Shi, J Y; Li, J; Li, K; Guan, Y Z; Cui, L Y

Tan, Y; Zhu, L; Huang, Y Y; Shi, J Y; Li, J; Li, K; Guan, Y Z; Cui, L Y.

Afiliação

Tan Y; Department of Neurology, Peking Union Medical College (PUMC)Hospital,Chinese Academy of Medical Science,Beijing 100730,China.
Zhu L; Department of Nuclear Medicine, Peking Union Medical College (PUMC)Hospital, Chinese Academy of Medical Science,Beijing 100730,China.
Huang YY; Department of Neurology, Peking Union Medical College (PUMC)Hospital,Chinese Academy of Medical Science,Beijing 100730,China.
Shi JY; Department of Neurology, Peking Union Medical College (PUMC)Hospital,Chinese Academy of Medical Science,Beijing 100730,China.
Li J; Department of Neurology, the First Hospital of Tsinghua University, Beijing 100016, China.
Li K; Department of Neurology, Peking Union Medical College (PUMC)Hospital,Chinese Academy of Medical Science,Beijing 100730,China.
Guan YZ; Department of Neurology, Peking Union Medical College (PUMC)Hospital,Chinese Academy of Medical Science,Beijing 100730,China.
Cui LY; Department of Neurology, Peking Union Medical College (PUMC)Hospital,Chinese Academy of Medical Science,Beijing 100730,China.

Zhonghua Yi Xue Za Zhi ; 101(31): 2433-2437, 2021 Aug 17.

Article em Zh | MEDLINE | ID: mdl-34399555

Assuntos

Autoanticorpos; Miastenia Gravis; Idade de Início; Feminino; Humanos; Imunossupressores/uso terapêutico; Masculino; Pessoa de Meia-Idade; Prognóstico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Autoanticorpos / Miastenia Gravis Tipo de estudo: Prognostic_studies Limite: Female / Humans / Male / Middle aged Idioma: Zh Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google